Centrexion Therapeutics Corp — Form D/A

Centrexion Therapeutics Corp of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2013-12-03. The offering totals $35.0M, of which $14.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (30)

Showing 25 of 30 people.

NameRoleLocation
Michael J WardExecutive OfficerChevy Chase, MD
Sol BarerDirectorNew Providence, NJ
Shawn R TomaselloDirectorBoston, MA
James N Campbell, M.D.DirectorBoston, MA
James N Campbell, M.D.Executive OfficerBoston, MA
Sol J Barer, Ph.D.DirectorBoston, MA
Colin J HillDirectorBoston, MA
Randall M StevensExecutive OfficerBoston, MA
Joseph R SwedishDirectorBoston, MA
Jeffrey B KindlerDirectorBoston, MA
Jeffrey B KindlerExecutive OfficerBoston, MA
J.C. J Lopez, M.D.DirectorBoston, MA
J. C Lopez, M.D.DirectorBOSTON, MA
Peter R WirthDirectorBoston, MA
Dezhi J Kang, Ph.D.DirectorBOSTON, MA
James N CampbellDirectorStrongsville, OH
James N CampbellExecutive OfficerStrongsville, OH
Daniel J MendelsonDirectorBOSTON, MA
Sara J NayeemDirectorBOSTON, MA
Stella R XuDirectorBOSTON, MA
Isaac BlechDirectorJupiter, FL
Gregg J BeloffExecutive OfficerBOSTON, MA
Arnold OronskyDirectorBOSTON, MA
Isaac J BlechDirectorBOSTON, MA
Shawn J TomaselloDirectorBOSTON, MA

Other filings by this issuer (16)

Showing 15 of 16 filings.

FiledFormOfferingSold
2024-01-08D$12.9M$3.3M
2023-11-27D$2.3M$2.3M
2023-07-11D/A$30.0M$10.3M
2023-06-29D$10.3M$10.3M
2022-08-11D/A$29.1M$29.1M
2022-06-28D/A$23.8M$23.8M
2022-06-08D$16.5M$16.5M
2021-01-26D$13.5M$13.5M
2018-01-02D$69.6M$69.6M
2017-05-23D$5.3M
2017-01-05D$16.6M$16.6M
2016-06-21D$11.2M
2016-04-15D$6.9M
2016-03-14D$10.5M
2013-12-03D$8.8M$8.8M

More